J Terrig Thomas1, David Prakash, Karis Weih
1Division of Cellular and Gene Therapies, Center for Biologics Evaluation and Research, United States Food and Drug Administration, Bethesda, Maryland 20892, USA. john.thomas@fda.hhs.gov
Cartilage-derived morphogenetic protein 1 (CDMP1/GDF5) requires proteolytic cleavage for biological activity. This activation mechanism explains its localized action during limb development, particularly at the articular surface.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: